This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Natural Alternatives International, Inc. Announces Chairman & CEO, Mark LeDoux, Named Chairman Of Natural Products Association ComPLI Committee

SAN MARCOS, Calif., Sept. 29, 2011 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Chairman and CEO, Mark A. LeDoux, has been selected by the Natural Products Association (NPA) to chair its Committee for Product and Label Integrity (ComPLI).  LeDoux has been a proud member of NPA since 1980 and serves on its board of directors.  He will focus on the development of NPA's comments for the Food and Drug Administration's (FDA) New Dietary Ingredient (NDI) draft guidance, as well as oversight of NPA's self-regulatory programs.

ComPLI advises NPA on scientific and regulatory matters pertaining to the dietary supplement industry and governs the Good Manufacturing Practices (GMP) certification and TruLabel programs. NPA's GMP certification program is the first third-party GMP certification program for the manufacturing of dietary supplements and ingredients. NPA helps to ensure accuracy, quality and safety in the dietary supplement industry through TruLabel, a dietary supplement label registration and random-testing program.  Learn more at

"As the leading voice of the natural products industry, NPA represents more than 1,900 members who support the health and well-being of millions of Americans. Mark's leadership with NPA's self-regulatory programs will benefit consumers and businesses across the country," said John Gay, NPA Executive Director and CEO.

Mark LeDoux stated, "I am honored to be asked to serve in this vital capacity for the NPA as well as the industry at large.  We need to continue to strengthen our resolve to assure the finest quality of products for the millions of people who have come to rely on our research, science and technology to provide beneficial supplements and products that are beyond reproach.  As we work to strengthen the proper role of the federal and state agencies to help us in that objective, we must also be ever mindful that too much regulation can stifle creativity and unnecessarily increase product costs.  Since safety remains our predominant concern, we also need to work with the regulatory agencies to help protect our consumers from materials masquerading as healthful products which can be criminally altered.  The goal of the ComPLI committee is to assure that the delicate balance between regulation and innovation remains intact while fostering advances in health for so many in need."

NAI, headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at

CONTACT – Kenneth Wolf, Chief Operating and Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or

Web site:

SOURCE Natural Alternatives International, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs